| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 7e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.23 | 0.0006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.009 |